Back to News
Market Impact: 0.75

Wrap Technologies, Inc. (WRAP) Q3 2025 Earnings Call Transcript

WRAPAXON
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsProduct LaunchesTechnology & InnovationRegulation & LegislationLegal & LitigationInfrastructure & Defense
Wrap Technologies, Inc. (WRAP) Q3 2025 Earnings Call Transcript

Wrap Technologies (WRAP) reported its strongest Q3 in two years, achieving $2 million in gross revenue, with 12% derived from subscription sales, signaling a successful transformation from a device manufacturer to a comprehensive provider of non-lethal response subscription solutions. The company is expanding its integrated ecosystem, which includes the BolaWrap 150 (boasting a 92% field success rate with no reported fatalities or serious injuries), WrapTactics training, WrapVision cameras, and drone-based MERLIN payloads, into federal, defense, and international markets. This strategic shift towards recurring revenue from integrated hardware, software, and training subscriptions is expected to drive margin expansion and profitability, positioning WRAP to capitalize on a significantly expanded total addressable market beyond traditional law enforcement.

Analysis

Wrap Technologies (WRAP) achieved its strongest Q3 in two years, reporting $2 million in gross revenue, with 12% derived from subscription-based sales. This reflects a successful strategic pivot from a device manufacturer to a comprehensive provider of non-lethal response subscription solutions, integrating hardware, software, and training. This shift towards recurring, higher-margin revenue streams is anticipated to drive margin expansion and profitability. The company's integrated ecosystem, featuring BolaWrap 150 (92% field success, 0 reported deaths/injuries), WrapTactics training, WrapVision, and MERLIN drone payloads, is expanding into federal, defense, and international markets. This significantly broadens WRAP's total addressable market, with the Counter-UAS segment alone projected to exceed $15 billion by 2030. The new Norton, VA facility supports a "Made in America" strategy and federal procurement eligibility. WRAP strongly differentiates its "non-lethal" technology from "less-lethal" alternatives, noting policy tightening around traditional tools (like TASER, which has negative sentiment) is accelerating BolaWrap adoption. Some departments report BolaWrap use outpacing TASER, driven by policy reform and community expectations. Policy alignment is now a critical third pillar alongside training and tools in their go-to-market strategy. Management is aggressively scaling its sales and marketing efforts, indicating a significant growth phase to capitalize on this expanded market opportunity. The company is also actively evaluating capital market options, including a public secondary offering, to fund future expansion and move away from past dilutive private placements.